NIH-funded research NIH-funded research

Understanding how specific receptors regulate inflammation in the lungs

Official title: RIG-I-like receptor regulation of pulmonary inflammation and homeostasis

Funded at Ohio State University · NIH-10901970 · Data updated 2026-11-12

This study is looking at how certain receptors in the lungs help control inflammation during illnesses, and it aims to find new ways to treat lung conditions by understanding how these receptors work with the immune system.

Quick facts

Grant typeNIH-funded research
Study typeNIH-funded research
Funding institutionOhio State University
NIH-funded
Lab location1 site (Columbus, UNITED STATES)
Project startSeptember 1, 2023
Project endJuly 31, 2028
Funding year2024
Award (this year)$393,750
NIH project number5R35GM150503-02
Project IDNIH-10901970 on NIH RePORTER

Who could benefit from this research

Could help

Ideal candidates for this research include individuals suffering from pulmonary inflammatory diseases or autoimmune conditions.

Less likely to help

Patients with non-inflammatory lung conditions or those not affected by immune system dysregulation may not benefit from this research.

What this research studies

This research investigates the role of RIG-I-like receptors (RLRs) in managing inflammation within the lungs during both infectious and non-infectious diseases. By examining how these receptors recognize different nucleic acids, the study aims to uncover their impact on immune responses and tissue repair. The approach includes using synthetic agonists to activate these receptors and studying their effects on immune cell programming and inflammatory signaling. This could lead to new treatment strategies for various inflammatory diseases affecting the lungs.

Why it matters

Potential benefit: If successful, this research could provide new therapeutic strategies for treating lung inflammation and related diseases.

How similar studies have gone: Previous research has shown promising results in understanding the roles of immune receptors in inflammation, suggesting that this approach could yield valuable insights.

Where this research is happening

  • Ohio State University
    Columbus, United States
    Active

Researchers

  • Principal investigator: Hemann, Emily Ann — Ohio State University
  • Study coordinator: Hemann, Emily Ann

Related research

Other NIH-funded projects on the same topics.

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.